PARKWAY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled Trial of Flumazenil for the Treatment of Obsessive Compulsive Disorder

Phase 2

Terminated

Conditions: Obsessive Compulsive Disorder

Interventions: Drug: Flumazenil

First Posted Date: 2009-10-16

Last Posted Date: 2014-04-22

Lead Sponsor: Parkway Medical Center

Target Recruit Count: 11

Registration Number: NCT00997087

Locations: 🇺🇸
James G. Sullivan, MD, Birmingham, Alabama, United States

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy